Welcome to our dedicated page for Select Medical news (Ticker: SEM), a resource for investors and traders seeking the latest updates and insights on Select Medical stock.
Select Medical Holdings Corp. (NYSE: SEM) is a prominent healthcare provider in the United States, specializing in four key areas: long-term acute care, inpatient medical rehabilitation, outpatient physical therapy, and contract therapy. The company's extensive network is supported by nearly 40,000 dedicated professionals who are committed to delivering high-quality care across the nation.
Select Medical's operations are divided into four main segments:
- Critical Illness Recovery Hospitals: Designed for patients needing extended recovery time and specialized medical services, this segment includes 107 hospitals across 28 states.
- Rehabilitation Hospitals: These facilities focus on helping patients regain their strength and functionality, comprising 33 hospitals in 12 states.
- Outpatient Rehabilitation Clinics: With 1,933 clinics in 39 states and the District of Columbia, this segment provides physical therapy and rehabilitation services.
- Concentra: This segment includes 544 occupational health centers and 150 onsite clinics at employer worksites, offering services such as workers' compensation injury care, physical exams, and preventive care.
Despite its significant growth, Select Medical remains dedicated to its foundational principles of clinical quality and operational excellence. The company's vision emphasizes putting patients first, constantly seeking improvement, and attracting top talent to deliver the best possible care.
In recent developments, Select Medical has been actively engaged in strategic initiatives to enhance its operations and financial performance. The company has announced plans for the potential separation of its Concentra business, aiming to create two independent, publicly traded entities. This move is intended to increase shareholder value and allow each company to focus on its core strengths.
Financially, Select Medical reported an estimated net operating revenue of approximately $1.67 billion for the second quarter of 2023, with an Adjusted EBITDA of about $219 million. The company continues to demonstrate robust financial health, with approximately $100 million in cash and $3.75 billion in indebtedness as of June 30, 2023.
Looking ahead, Select Medical remains committed to expanding its footprint and enhancing the quality of care provided to its patients. The company regularly updates its stakeholders through earnings calls and press releases, ensuring transparency and engagement with its investor base.
Select Medical Holdings (NYSE: SEM) announced its Q4 and full-year 2024 results, along with its 2025 outlook and dividend declaration. Key highlights include:
The company completed a tax-free distribution of Concentra shares on November 25, 2024. Q4 2024 revenue increased 7.8% to $1,312.6 million, though the company reported a loss from continuing operations of $10.5 million, impacted by a one-time $45.9 million stock compensation expense and $17.9 million debt refinancing loss.
For full-year 2024, revenue grew 7.5% to $5,187.1 million, with income from continuing operations increasing 17.7% to $130.0 million. The board declared a cash dividend of $0.0625 per share, payable March 13, 2025. The company also maintains a $1.0 billion stock repurchase program through December 31, 2025.
The 2025 business outlook projects revenue between $5.4-5.6 billion and Adjusted EBITDA of $520.0-540.0 million.
Select Medical Holdings (NYSE: SEM) has scheduled its fourth quarter and full year 2024 financial results release for Thursday, February 20, 2025, after market close. The company will host a conference call to discuss results and business outlook on Friday, February 21, 2025, at 9:00am ET.
As of December 31, 2024, Select Medical operates 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,914 outpatient rehabilitation clinics across 39 states and the District of Columbia. The company's operations span 41 states and D.C., making it one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.
Select Medical Holdings (NYSE: SEM) announced that its subsidiary, Select Medical , has completed a private offering of $550.0 million in 6.250% senior notes due 2032. The notes are senior unsecured obligations guaranteed by certain domestic subsidiaries.
The proceeds from the offering, along with new incremental term loan and cash on hand, will be used to repay existing term loans, redeem outstanding 6.250% senior notes due 2026, and cover related fees and expenses. The notes were offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
Concentra (NYSE: CON) announced the completion of its spin-off from Select Medical through the distribution of 104,093,503 shares, representing 81.7% of Concentra's outstanding common stock. Select Medical stockholders received 0.806971 Concentra shares for each Select Medical share held as of November 18, 2024. Concentra, the largest U.S. occupational health services provider, operates 549 health centers and 156 onsite clinics across 45 states, serving over 50,000 patients daily with 11,000 colleagues and affiliated medical professionals.
Select Medical Holdings (NYSE: SEM) has completed the distribution of 104,093,503 shares (81.7%) of Concentra (NYSE: CON) common stock to its stockholders. The distribution occurred on November 25, 2024, with stockholders receiving 0.806971 Concentra shares for each Select Medical share held as of the November 18, 2024 record date. Following this spin-off, Select Medical no longer holds any Concentra shares. J.P. Morgan and Goldman Sachs served as financial advisors for the distribution.
Select Medical Holdings (NYSE: SEM) has announced the distribution ratio for its special stock distribution of Concentra Group Holdings Parent equity to stockholders. Shareholders will receive 0.806971 shares of Concentra's common stock for each Select Medical share held as of November 18, 2024 (Record Date). The distribution will occur on November 25, 2024, with cash provided in lieu of fractional shares. The distribution is intended to be tax-free for U.S. federal income tax purposes. J.P. Morgan and Goldman Sachs are serving as financial advisors, while Dechert LLP is acting as legal advisor for the distribution.
Select Medical Holdings (NYSE: SEM) announced that its subsidiary, Select Medical , has priced a $550.0 million private offering of 6.250% senior notes due 2032. The offering is expected to close on December 3, 2024. The notes will be senior unsecured obligations guaranteed by certain domestic subsidiaries.
The company plans to use the proceeds, along with a new incremental term loan and cash on hand, to repay existing term loans, redeem outstanding 6.250% senior notes due 2026, and cover related fees. The notes will be offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
Select Medical Holdings (NYSE: SEM) announced that Select Medical has initiated a private offering of $850 million in senior notes due 2032. The company plans to amend its existing senior secured credit agreement to establish a new incremental term loan and extend its revolving credit facility maturity. The proceeds will be used to repay existing term loans, redeem all outstanding 6.250% senior notes due 2026, and cover related fees. The notes will be offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
Select Medical Holdings has announced a special stock distribution of its Concentra holdings to shareholders. The distribution will occur on November 25, 2024, with a record date of November 18, 2024. Stockholders will receive approximately 0.806971 shares of Concentra's common stock (NYSE: CON) for each share of Select Medical stock held. The distribution represents about 81.7% of Concentra's outstanding shares, totaling 104,093,503 shares. The transaction is intended to be tax-free for U.S. federal income tax purposes, and no stockholder action is required. Cash will be provided in lieu of fractional shares.
Select Medical Holdings (NYSE: SEM) reported strong Q3 2024 financial results with significant growth across key metrics. Revenue increased 5.7% to $1,761.2 million, while net income rose 33.2% to $81.0 million. The company saw improved performance across all segments, with notable growth in rehabilitation hospitals (14.4% revenue increase) and outpatient rehabilitation (6.9% revenue increase).
The company declared a cash dividend of $0.125 per share, payable around November 26, 2024, to stockholders of record as of November 13, 2024. Additionally, Select Medical updated its 2024 outlook, projecting revenue between $6.95-7.15 billion and Adjusted EBITDA of $865.0-885.0 million.
FAQ
What is the current stock price of Select Medical (SEM)?
What is the market cap of Select Medical (SEM)?
What are the main segments of Select Medical Holdings Corp.?
Where is Select Medical Holdings Corp. headquartered?
How many employees does Select Medical have?
What is the focus of Select Medical's Concentra segment?
What recent financial achievements has Select Medical reported?
Is Select Medical planning any strategic changes?
How can investors stay updated on Select Medical's performance?
How many rehabilitation hospitals does Select Medical operate?
What is Select Medical's vision?
Where can I find detailed information about Select Medical's financial performance?
